StockGlow

Beijing Luzhu Biotechnology Co., Ltd. (2480.HK)

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China.

14.00+0.00%Healthcare
Compare 2480.HK with
StockGlow Score
23
Leaning Bearish
BearishBullish
1 year ago-40.4%

The outlook

Beijing Luzhu Biotechnology Co., Ltd. currently reads as leaning bearish based on below its 50- & 200-day averages, 13% of the way from its 52-week low to high, avg target +124% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +124% vs current price
Market cap
$2.78B
52-wk high
28.00
52-wk low
12.00
50-day avg
14.22
200-day avg
20.73
Trailing P/E
—

Similar stocks

2487.HKCutia Therapeutics$2.34-2.50%2496.HKWuhan YZY Biopharma Co., Ltd.$3.69-2.89%2442.HKEasy Smart Group Holdings Limited$59.10+2.60%2415.HKMedSci Healthcare Holdings Limited$0.72-1.37%2402.HKBeijing SinoHytec Co., Ltd.$12.67+4.37%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy